Screener
Insight Molecular Diagnostics Inc. IMDX Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Kitted Products | $21K-12.5% | $0— | $0— | $0— | $24K— | |
| Laboratory Services | $218K-55.9% | $32K-98.5% | $1.14M-23.4% | $260K+126% | $494K+375% | |
| Revenue by Geography | ||||||
| Asia Pacific | $6K— | —— | $0— | $0— | $0-100% | |
| Europe | $15K-37.5% | —— | —— | $0— | $24K— | |
| US | $218K-55.9% | $32K-98.5% | $1.14M-22.5% | $260K+126% | $494K+637% |
FAQ
- How does Insight Molecular Diagnostics Inc. break its business down?
- Insight Molecular Diagnostics Inc. (IMDX) reports revenue by product across 2 parts — Kitted Products and Laboratory Services. Each is extracted from the segment footnotes and tracked over time.
- Where does Insight Molecular Diagnostics Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Insight Molecular Diagnostics Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
